FDA issued a Warning Letter to Cadila Healthcare Limited on 6/21/2011 for a previous inspection.
483 Cadila Healthcare May 2019

483 Cadila Healthcare May 2019

Thomas Arista FDA, Justin Boyd FDA, Rita Kabaso FDA$119.00 - Available Now

FDA investigators audited the Cadila Healthcare - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 03 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 03 May 2019
  • Location: Ahmedabad, India
  • FEI: 3002984011
Add To Cart